多替阿巴拉米片售价多少一盒？

Developed by ViiV Healthcare (a joint venture of GSK and Pfizer), it was approved by the US FDA on August 27, 2014 for the treatment of human immunodeficiency virus (HIV).

On January 22, 2018, GlaxoSmithKline (GSK) announced that its new drug Suimeike (generic name: dolutegravir tablets) for the treatment of HIV was officially launched in mainland China. This is a single-pill compound preparation with the new generation integrase inhibitor dolutegravir (DTG) as the core. It is also the first single-pill compound preparation with a complete treatment plan in the field of HIV treatment in mainland China.

How much does a box of Dota Abalami Tablets cost?

The current price of Doceta abalami tablets in the Chinese market is $2,880/month. Since they have not yet entered into medical insurance, many patients face great financial pressure if they need to take medication for a long time. You may wish to choose the Doceta abalami tablets produced by the Indian company Emcure. There are 30 tablets in a box. The price is equivalent to RMB 1,000. The therapeutic effect is the same as that of the domestic original drug. This is also the most cost-effective one at present.

Dolutegravir tablets are a compound preparation that mainly contains three ingredients, namely dolutegravir 50mg + abacavir 0.6g + lamivudine 0.3g. One tablet is a complete treatment regimen. Moreover, the method of use of Suimeikai is simple. One tablet a day can achieve the effect of cocktail therapy without food restrictions, which greatly improves the patient's medication compliance. In terms of therapeutic effect, it can also significantly inhibit the virus, has smaller side effects, and is less likely to develop drug resistance.

The launch of the drug has brought new treatment options to HIV patients and effectively improved their quality of life. If you need to buy the Indian version of Dolutegra Abalami Tablets, you can go to a regular pharmacy in India to buy it yourself, or you can consult our medical companion travel service for purchasing information.